The following are some of the stocks that moved up in after-hours trading on Monday.
BrainStorm Cell Therapeutics Inc. (BCLI) is expected to provide an update on its investigational mesenchymal stem cell therapy NurOwn program tomorrow, April 9, at 8:00 AM Eastern Time. NurOwn is being developed for the treatment of amyotrophic lateral sclerosis (ALS), a rare disease that attacks and kills the nerve cells controlling voluntary muscles. The company had withdrawn its Biological License Application for NurOwn in ALS, after an FDA panel voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com